Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 225,582 | 105,187 | 71,425 | 648,607 | 71,791 |
| Marketable Securities | 488,182 | 307,487 | 114,817 | N/A | N/A |
| Receivables | 6,537 | 11,076 | 3,470 | 7,619 | 24,320 |
| Other current assets | 0 | 0 | 0 | 486 | 1,201 |
| TOTAL | $720,301 | $423,750 | $189,712 | $656,712 | $97,312 |
| Non-Current Assets | |||||
| PPE Net | 1,059 | 254 | 204 | 906 | 694 |
| Intangibles | 2,001 | 1,864 | 1,893 | 1,798 | 12,408 |
| Other Non-Current Assets | 27,821 | 9,692 | 11,140 | 4,752 | 2,960 |
| TOTAL | $30,881 | $11,810 | $13,237 | $7,456 | $16,062 |
| Total Assets | $751,182 | $435,560 | $202,949 | $664,168 | $113,374 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,292 | 4,636 | 2,667 | 355 | 4,374 |
| Accrued Expenses | 47,025 | 31,531 | 14,212 | 16,305 | 11,322 |
| Other current liabilities | 2,283 | 1,797 | 717 | 20,432 | 897 |
| TOTAL | $72,988 | $41,729 | $20,405 | $38,782 | $25,623 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 100,000 | 494,540 | N/A |
| Deferred Revenues | N/A | N/A | N/A | N/A | 7,939 |
| Other Non-Current Liabilities | 19,334 | 5,083 | 4,852 | 4,192 | 4,467 |
| TOTAL | $19,334 | $5,083 | $104,852 | $498,732 | $4,467 |
| Total Liabilities | $92,322 | $46,812 | $125,257 | $537,514 | $30,090 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 775,373 | 737,680 | 701,697 | 697,685 | 98,122 |
| Common Shares | 7,754 | 7,376 | 7,017 | 2,110 | 980 |
| Retained earnings | -2,294,159 | -1,214,573 | -993,258 | -378,330 | -299,548 |
| Other shareholders' equity | -2,540 | -2,285 | -2,448 | -1,893 | -2,197 |
| TOTAL | $658,860 | $388,748 | $77,692 | $126,654 | $83,284 |
| Total Liabilities And Equity | $751,182 | $435,560 | $202,949 | $664,168 | $113,374 |